Abstract
The influence of substituents on the yields of the synthesis of seven catechines analogues has been studied. 3-Flavene formation is favoured by electron donors substituents on the A and B rings. Yields of the hydroboration reaction are increased by electron donor substituents on the A ring, while substituents on the B ring do not affect the reaction outcome.
Keywords: Gallocatechin, catechins, total synthesis, structure-reactivity study, EGCG
Letters in Organic Chemistry
Title: Synthesis of Gallocatechin-3-Gallate Analogues
Volume: 4 Issue: 4
Author(s): Nadia Vaiana, Luca Rizzi, Maria G. Pezzano, Roberto Restelli, Filippo Rota, Silvia Stefanini, Silvia Vicentini and Sergio Romeo
Affiliation:
Keywords: Gallocatechin, catechins, total synthesis, structure-reactivity study, EGCG
Abstract: The influence of substituents on the yields of the synthesis of seven catechines analogues has been studied. 3-Flavene formation is favoured by electron donors substituents on the A and B rings. Yields of the hydroboration reaction are increased by electron donor substituents on the A ring, while substituents on the B ring do not affect the reaction outcome.
Export Options
About this article
Cite this article as:
Nadia Vaiana , Luca Rizzi , Maria G. Pezzano , Roberto Restelli , Filippo Rota , Silvia Stefanini , Silvia Vicentini and Sergio Romeo , Synthesis of Gallocatechin-3-Gallate Analogues, Letters in Organic Chemistry 2007; 4 (4) . https://dx.doi.org/10.2174/157017807781024291
DOI https://dx.doi.org/10.2174/157017807781024291 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative Stress on Progenitor and Stem Cells in Cardiovascular Diseases
Current Pharmaceutical Biotechnology Comparison of Valvulopathy Risk with Lorcaserin and Phenterminetopiramate for Weight Loss
Current Drug Therapy Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy
Current Pharmacogenomics Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
Current Drug Metabolism Preoperative Pulmonary Assessment: A Review
Current Respiratory Medicine Reviews Dietary Carotenoids in Managing Metabolic Syndrome and Role of PPARs in the Process
Current Nutrition & Food Science Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
Current Drug Targets Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Effect of Androgenic and Antiandrogenic Acting Compounds in Macrophage Accumulation and Cell Replication in the Aorta of Oophorectomized Hypercholesterolemic Rabbits
Vascular Disease Prevention (Discontinued) Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry Diagnosis of Surgically-Treatable Forms of Primary Aldosteronism
Current Hypertension Reviews Subject Index Volume 2
Current Pediatric Reviews Diabetic Cardiomyopathy: Clinical and Metabolic Approach
Current Vascular Pharmacology Vascular Remodelling in Well-controlled Hypertensive Patients: The Challenge of Residual Risk Management
Current Pharmaceutical Design Mitochondrial Dysfunction and Lipid Homeostasis
Current Drug Metabolism Editorial: Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?
Current Vascular Pharmacology Kinins and Cardiovascular Diseases
Current Pharmaceutical Design New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC
Current Signal Transduction Therapy Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design The GSTM1 and GSTT1 Null Genotypes Increase the Risk for Type 2 Diabetes Mellitus and the Subsequent Development of Diabetic Complications: A Meta-analysis
Current Diabetes Reviews